Recently, it has been reported that hyperglucagonemia correlates with NAFLD, not with altered glycemia in humans (9) and that the liver with NAFLD has glucagon resistance in regulation of amino acid metabolism (88). Here, GCG is linked to metabolic dysfunction-associated steatotic liver disease.